In this issue, we cover the latest indicators pointing towards the growing possibility for a bear market. We also cover the upcoming options expirations set to take place after the close of trading today.
This coming January will mark two years since we launched Tech Frontiers and its predecessor, Biotech Frontiers. During that time, we’ve compiled an extraordinary track record: Eight of our recommendations have appreciated over 100% and many others have appreciated at least 50%. In the meantime, in our biotech portfolio, we encountered only two meaningful losers
This month’s recommendation looks at a real estate investment trust, or REIT, that has a very low level of risk, and that is supported by a huge dividend that is well above almost any fixed-income instrument in the market today.
Today, Porter warns that a popular retailer has begun a terminal decline – much like he correctly predicted for Sears and J.C. Penney years ago – that will end in bankruptcy by the end of the decade.
Today, Porter shares the one investing secret that he plans to share with his kids. Here’s the best part for you. If a significant portion of your wealth is invested this way, you never have to worry about what the market is going to do.
In our report Dig Baby Dig, published on September 12, 2024, we recommended purchasing Albemarle’s 7.25% Series A Mandatory Convertible Preferred Stock, then trading at $42.89 per share. Our rationale was that the sharp decline in lithium prices had caused the stock prices of the companies, like Albemarle, that produce it, to fall too far.
The last great computer revolution (the internet boom) was run by multiple companies that controlled the key enabling technologies: Intel, Cisco, Microsoft, Apple, and Oracle. With the parallel processing revolution, Porter writes, it’s all Nvidia.
Today, we’re recommending a series of trades designed to reduce portfolio risk and raise cash. We plan to execute all five of these trades at the prevailing market prices on Friday, October 31.